tiprankstipranks
Immutep Reports Promising Phase II Sarcoma Trial Results
PremiumCompany AnnouncementsImmutep Reports Promising Phase II Sarcoma Trial Results
2M ago
Immutep price target raised to $7 from $6 at Baird
Premium
The Fly
Immutep price target raised to $7 from $6 at Baird
2M ago
Immutep’s Promising Lung Cancer Trial Results
Premium
Company Announcements
Immutep’s Promising Lung Cancer Trial Results
2M ago
Immutep announces first-in-human phase I study of IMP761
PremiumThe FlyImmutep announces first-in-human phase I study of IMP761
3M ago
Immutep completes enrolment in Phase 2 trial of AIPAC-003 in breast cancer
Premium
The Fly
Immutep completes enrolment in Phase 2 trial of AIPAC-003 in breast cancer
4M ago
Immutep Advances Breast Cancer Immunotherapy Trial
Premium
Company Announcements
Immutep Advances Breast Cancer Immunotherapy Trial
4M ago
Immutep: Quarterly Rebalance of S&P/ASX Indices
PremiumCompany AnnouncementsImmutep: Quarterly Rebalance of S&P/ASX Indices
4M ago
Immutep Reports Increased Loss Despite Higher Income
Premium
Company Announcements
Immutep Reports Increased Loss Despite Higher Income
5M ago
Immutep Launches Groundbreaking Autoimmune Therapy Trial
Premium
Company Announcements
Immutep Launches Groundbreaking Autoimmune Therapy Trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100